M214-5

Blood: MRSA  – February 07, 2022

HISTORY

A simulated blood culture sample collected from a 34-year-old person with substance use disorder was sent to category A laboratories. Participants were expected to report MRSA and report susceptibility results.

MAIN EDUCATIONAL POINTS from M214-5

  1. Monitoring the susceptibility to vancomycin using MIC is required to prevent treatment failure in bloodstream infections
  2. There is an increased risk of invasive MRSA infections in IV drug users in North America.

Full critique (PDF)

Posted in Clinical Bacteriology Results, critiques Tagged with: